Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.12+0.82 (+15.47%)
Close on Nov 11, 2026Market cap $91.70MP/E –Yield –
Cumberland Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cumberland Pharmaceuticals's enterprise value was $87.50M on Nov 11, 2026, against $18.29M a year earlier. Over the last 5 years it ranged from -$1.88M to $113.12M, with a median of $15.94M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $87.50M | +98.8% |
| 2025 | Dec 31, 2025 | $44.01M | +185.2% |
| 2024 | Dec 31, 2024 | $15.43M | +132.7% |
| 2023 | Dec 29, 2023 | $6.63M | -47.7% |
| 2022 | Dec 30, 2022 | $12.67M | -70.8% |
| 2021 | Dec 31, 2021 | $43.33M | +143.9% |
| 2020 | Dec 31, 2020 | $17.77M | -65.5% |
| 2019 | Dec 31, 2019 | $51.44M | -7.0% |
| 2018 | Dec 31, 2018 | $55.29M | -25.2% |
| 2017 | Dec 29, 2017 | $73.96M | +38.4% |
| 2016 | Dec 30, 2016 | $53.42M | +5.3% |
| 2015 | Dec 31, 2015 | $50.72M | -21.2% |
| 2014 | Dec 31, 2014 | $64.33M | +38.0% |
| 2013 | Dec 31, 2013 | $46.61M | +57.4% |
| 2012 | Dec 31, 2012 | $29.61M | -21.2% |
| 2011 | Dec 30, 2011 | $37.60M | +23.2% |
| 2010 | Dec 31, 2010 | $30.52M | – |
See a number that looks wrong?